The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

With your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the ...

This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

In the U.S., the least active 25% of the population over 40 could add 11 years to their average life expectancy if they were ...

Adding just five minutes of activity a day could lower systolic blood pressure (the top number in a blood pressure reading) ...

Older adults who reported excessive daytime sleepiness and a lack of enthusiasm were more likely to develop a condition that ...

People whose choice of alcoholic beverage is exclusively beer tend to have particularly poor diets. They also are more likely ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...